Jerel Davis and Marcelo Bigal (Versant)
'It's pure art': Versant, GV reveal $60M bet that a clearer look at inflammasomes can lead to better drugs
For years, scientists had known about the myriad ways NLRP3 pushes the innate immune system to go overboard and trigger autoimmune or inflammatory diseases. But …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
